FDA Adverse Event Other Summary report: N

VIASPAN

MDR report key: 2511638 · Received March 26, 2012

Report

Report Number
3003708554-2012-00001
Event Type
Other
Date Received
March 26, 2012
Date of Event
March 19, 2012
Report Date
March 26, 2012
Manufacturer
FRESENIUS KABI AUSTRIA GMBH
Product Code
KDL
PMA / PMN Number
K944866
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL STERILITY TESTS ON PRIOR AND SUBSEQUENT VIASPAN BATCHES WERE INITIATED WITH RESULTS EXPECTED IN (B)(6) 2012. AT THE TIME OF REPORTING THERE HAVE BEEN NO REPORTED ADVERSE EVENTS, STABILITY OR PRODUCT STERILITY FAILURES. ADDITIONAL INFO WILL BE PROVIDED AS IT BECOMES AVAILABLE.

Description of Event or Problem · 1

ON (B)(6) 2012: CASE DESCRIPTION: 510K: K944866, PRODUCT NUMBER: 333-50-1000004606, FRESENIUS (B)(4), MFR OF VIASPAN (TEVA PRODUCT NUMBER; K944866), NOTIFIED TEVA ON (B)(6) 2012 OF A MEDIA-FILL FAILURE THAT SUPPORTED THE ASEPTIC MFG FOR VIASPAN POTENTIALLY IMPACTED LOTS: 16EK0007 AND 16EK0193. FRESENIUS INITIATED A DEVIATION AND THEIR INVESTIGATION IS CONTINUING. VISUAL EXAMINATION OF THE MEDIA FILL BAGS IDENTIFIED TURBIDITY IN (B)(4) BAGS. INITIAL ANALYSIS AND INVESTIGATION APPEARS TO HAVE IDENTIFIED A SMALL LEAK IN ONE OF THE MEASUREMENT DEVICES IN (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VIASPAN SET, PERFUSION, KIDNEY, DISPOSALBE KDL FRESENIUS KABI AUSTRIA GMBH

Patients

Seq Age Sex Outcome Treatment
1